Bioisosteric Replacement

Bioisosterism is the strategic replacement of a specific functional group or structural fragment within a lead compound with an alternative group — a...

Bioisosterism is the strategic replacement of a specific functional group or structural fragment within a lead compound with an alternative group — a bioisostere — that presents similar steric, electronic, or hydrogen-bonding characteristics and is therefore expected to preserve or improve biological activity while altering other molecular properties in a desired direction. Classical bioisosteric replacements include the substitution of a carboxylic acid with a tetrazole ring (preserving the acidic, hydrogen-bond-accepting character while improving metabolic stability and membrane permeability) and the replacement of an amide bond with alternative linkages resistant to proteolytic or hydrolytic cleavage. Bioisosteric replacement is among the most powerful and widely applied strategies in lead optimization precisely because it offers a rational, mechanistically grounded route to addressing a specific structural liability — metabolic instability, poor solubility, or an unfavourable toxicological alert — without discarding the core pharmacophoric interactions responsible for the compound's biological activity.